Psomagen, Inc. engages in the provision of genomic, transcriptomic, and proteomic analysis to research programs and operations, serving academic, pharma, biotech, government, and industry. It develops technologies such as short and long-read next-generation sequencing (NGS), Sanger (CE) sequencing, microarray, single-cell omics, metagenomics and microbiome, spatial biology, bioinformatics, and biomarker discovery. The company was founded on December 2, 2004 and is headquartered in Rockville, MD.